Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 22, 2017
Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell TransplantationDana T Lounder, Pooja Khandelwal, Sharat Chandra, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2016
A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus-Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients with Nonmalignant DiagnosesPooja Khandelwal, Tsuyoshi Fukuda, Kana Mizuno, et al.Blood|July 15, 2017
Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHDNicholas J Gloude, Pooja Khandelwal, Nathan Luebbering, et al.Pediatric Transplantation|March 24, 2020
Ibrutinib for the treatment of chronic graft-vs-host disease in pediatric hematopoietic stem cell transplant patients: A single-center experienceAshley Teusink-Cross, Stella M Davies, Michael S Grimley, et al.Blood|March 11, 2017
Lower levels of vitamin A are associated with increased gastrointestinal graft-versus-host disease in childrenDana T Lounder, Pooja Khandelwal, Christopher E Dandoy, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 24, 2019
CD38<sup>bright</sup>CD8<sup>+</sup> T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking CellsPooja Khandelwal, Vijaya Chaturvedi, Erika Owsley, et al.Journal of Clinical Immunology|October 17, 2020
Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring MyeloablationSharat Chandra, Shanmuganathan Chandrakasan, Blachy J Dávila Saldaña, et al.Pediatric Transplantation|January 4, 2014
The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patientsPooja Khandelwal, Julia Lawrence, Alexandra H Filipovich, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 28, 2017
Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant PatientsPooja Khandelwal, Ashley Teusink-Cross, Stella M Davies, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2018
Single Ultra-High-Dose Cholecalciferol to Prevent Vitamin D Deficiency in Pediatric Hematopoietic Stem Cell TransplantationGregory Wallace, Sonata Jodele, Kasiani C Myers, et al.Pageof 6